Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 20, Issue 2, February 1995

MONOGRAPHS

Amphotericin B Lipid Complex. Liposomal antifungal. R.A. Fromtling

Cerebrocrast. Neuroprotectant, cognition enhancer. V. Klusa

Copolymer-1. Agent for multiple sclerosis. J. Prous, N. Mealy, J. Castañer

Fampridine. Agent for multiple sclerosis. J. Prous, N. Mealy

LY191704. Type I steroid 5a-reductase inhibitor, treatment of androgenic alopecia. B.L. Neubauer et al.

Recombinant Human Platelet Factor 4. Antineoplastic, angiogenesis inhibitor, heparin inactivator. C. Robinson

SM-12502. Treatment for DIC, PAF antagonist. S. Morooka et al.

REVIEW ARTICLES

Lipophilic muscarinic M2 antagonists as potential drugs for cognitive disorders: Henri N. Doods

Phosphatidylinositol 3-kinase inhibitors and their effects on cell signaling pathways: Chris L. Valhos

New trends in medicinal chemistry: Petr Kocis

Information Update 1-19
Adinazolam
Bemoradan
Binospirone Mesylate
Brodimoprim
Broxaterol
Cefclidin
Clopidogrel Hydrogensulfate
Darodipine
Dirithromycin
Dizocilpine
Eptastigmine Tartrate
Gusperimus Hydrochloride
Ifetroban Sodium
KBT-3022
KC-764
KT-6149
Lazabemide Hydrochloride
Leurubicin
Levetiracetam
Lometrexol
7-Methoxytacrine
Methylprednisolone Aceponate
Mitoflaxone
Modafinil
Nimodipine
NK-611
NKH-477
Olanzapine
Omeprazole
Ormaplatin
Pranidipine
Propentofylline
Quinotolast Sodium
Retelliptine
Ritipenem Sodium
RS-21607-197
Selegiline
SM-9018
SNX-111
Stobadine
TA-0910
Tacalcitol
Tirilazad Mesylate
TJ-48
Yuehchukene


 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy